GeminIQ Website Logo

Viewing IRMD free

Subscribe for full history, 90+ metrics, screener, watchlist...

IRADIMED CORP

IRMD

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
595651575350525249455047
Accounts Receivable Net Current
131314141113111012131213
Inventory Net
121212121111101112131312
Prepaid Expense And Other Assets Current
125122211111
Prepaid Taxes
13-20-------
Assets Current
878681857775757474727672
Property Plant And Equipment Net
242424242320171410999
Finite Lived Intangible Assets Net
333333333332
Operating Lease Right Of Use Asset
-----0000222
Deferred Income Tax Assets Net
000233323222
Other Assets Noncurrent
000000000000
Assets
115114109115106102989490889287
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
222223211123
Employee Related Liabilities Current
323432433232
Accrual For Taxes Other Than Income Taxes Current
10-000000000
Product Warranty Accrual Classified Current
000000000000
Contract With Customer Liability Current
333333233232
Dividends Payable Current
----------8-
Operating Lease Liability Current
-----0000000
Other Liabilities Current
--0---000000
Accrued Income Taxes Current
0423-1---10-
Liabilities Current
9121013989878168
Contract With Customer Liability Noncurrent
444433333333
Operating Lease Liability Noncurrent
------000222
Liabilities
131614161212121110122113
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
323130323131303029292828
Retained Earnings Accumulated Deficit
706764666359575450474347
Accumulated Other Comprehensive Income Loss Net Of…
-----------0
Stockholders Equity
1029995989490878380767175
Liabilities And Stockholders Equity
115114109115106102989490889287
Allowance For Doubtful Accounts Receivable Current
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
323232323232323232323232
Common Stock Shares Issued
131313131313131313131313
Shares Outstanding
131313131313131313131313

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20265.92%6.04%11.59%---------
202511.02%16.69%8.03%10.07%6.83%11.24%11.05%16.70%20.78%-1.38%-10.17%-6.49%
2024-3.01%-1.82%3.44%-0.34%4.32%12.64%8.34%11.23%20.43%0.04%1.78%-2.17%
2023----1.82%-9.83%-19.29%-4.44%4.26%-0.15%2.46%-2.84%-0.05%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
9.46
7.13
7.98
6.64
8.78
8.87
8.84
9.21
9.87
9.44
4.65
9.13
Quick Ratio
7.97
6.02
6.37
5.63
7.29
7.44
7.38
7.70
8.11
7.64
3.80
7.55
Working Capital
77.56M
74.30M
71.02M
72.12M
68.56M
66.66M
66.73M
66.22M
66.12M
64.27M
59.67M
64.05M
Leverage & Debt
Debt to Equity
0.13
0.16
0.15
0.17
0.13
0.13
0.13
0.13
0.13
0.16
0.29
0.17
Debt Ratio
0.12
0.14
0.13
0.14
0.11
0.11
0.12
0.11
0.11
0.14
0.23
0.15
Efficiency & Turnover
Asset Turnover TTM
0.78
0.80
0.81
0.77
0.79
0.79
0.77
0.79
0.81
0.83
0.74
0.75
Days Sales Outstanding TTM
50.97
55.25
52.74
54.91
53.77
62.49
56.76
59.25
60.50
66.22
70.98
67.91
Receivables Turnover TTM
7.16
6.61
6.92
6.65
6.79
5.84
6.43
6.16
6.03
5.51
5.14
5.37
Per Share Metrics
Diluted EPS TTM
1.79
1.83
1.75
1.65
1.61
1.54
1.50
1.46
1.46
1.41
1.35
1.28
Free Cash Flow Per Share TTM
1.96
1.91
1.35
1.16
1.12
1.15
1.39
1.41
1.07
0.90
0.48
0.43
Dividend Per Share TTM
1.24
1.21
1.18
0.66
0.64
0.62
1.08
0.93
0.78
0.63
1.05
1.05
Margin Metrics
Gross Profit Margin TTM
75.86%
76.84%
76.75%
77.07%
76.96%
76.91%
76.94%
77.14%
77.21%
76.57%
76.50%
76.17%
Operating Profit Margin TTM
31.91%
32.40%
31.20%
30.87%
30.67%
30.14%
29.99%
29.91%
30.86%
30.70%
30.56%
30.38%
Net Profit Margin TTM
26.70%
27.36%
26.82%
26.31%
26.61%
26.32%
26.26%
26.12%
26.83%
26.48%
26.22%
25.93%
Growth Metrics
Net Revenue Growth (1Y)
11.21%
14.81%
14.43%
12.91%
11.73%
11.04%
11.71%
13.23%
16.05%
19.87%
23.00%
25.17%
Net Income Growth (1Y)
11.61%
19.34%
16.88%
13.73%
10.79%
10.38%
11.87%
14.09%
26.95%
30.37%
34.02%
25.13%
EPS Growth (1Y)
11.01%
18.70%
16.40%
13.27%
10.35%
9.94%
11.28%
13.48%
26.26%
29.66%
33.59%
24.76%
Valuation Metrics
P/E TTM
52.87
51.88
54.69
42.15
36.22
33.08
35.43
33.36
29.01
30.10
33.70
32.71
P/B TTM
11.98
12.43
12.99
9.08
7.93
7.27
7.85
7.45
6.79
7.09
8.11
7.16
P/S TTM
14.12
14.20
14.67
11.09
9.64
8.71
9.30
8.71
7.78
7.97
8.84
8.48
Market Cap
1.22B
1.22B
1.23B
892.88M
748.12M
654.49M
681.49M
621.37M
540.88M
539.49M
579.43M
534.07M
Enterprise Value
1.16B
1.17B
1.18B
836.35M
695.12M
604.16M
629.25M
569.65M
492.34M
494.36M
529.67M
487.33M
Calculated Values
Free Cash Flow TTM
25.12M
24.47M
17.18M
14.75M
14.21M
14.60M
17.62M
17.80M
13.58M
11.39M
6.02M
5.42M
Net Debt
-59.08M
-56.37M
-51.16M
-56.53M
-53.00M
-50.33M
-52.23M
-51.72M
-48.54M
-45.13M
-49.76M
-46.75M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-04Sale
Owner: Scharen-Guivel, Hilda Fre…
Title: -
Shares: 3,000
Price/Share: $95.00
Value: $285,000.00
Shares Owned: 5,598
Relationship: Director
Ownership: Direct
2026-06-01Sale
Owner: Susi, Roger E.
Title: CEO, President, Chairman
Shares: 2,500
Price/Share: $90.36
Value: $225,900.00
Shares Owned: 2,162,500
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-05-27Sale
Owner: Susi, Roger E.
Title: CEO, President, Chairman
Shares: 2,500
Price/Share: $92.23
Value: $230,575.00
Shares Owned: 2,165,000
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-05-19Sale
Owner: Susi, Roger E.
Title: CEO, President, Chairman
Shares: 2,500
Price/Share: $87.97
Value: $219,925.00
Shares Owned: 2,172,500
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-05-12Sale
Owner: Susi, Roger E.
Title: CEO, President, Chairman
Shares: 4,411
Price/Share: $84.15
Value: $371,185.65
Shares Owned: 2,180,000
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
53.67%
Inst. Shares: 6,861,043
Shares Outstanding: 12,783,000
2025-12-31
52.95%
Inst. Shares: 6,736,541
Shares Outstanding: 12,722,000
2025-09-30
51.61%
Inst. Shares: 6,565,201
Shares Outstanding: 12,720,812
2025-06-30
52.77%
Inst. Shares: 6,710,508
Shares Outstanding: 12,715,872
2025-03-31
52.22%
Inst. Shares: 6,638,620
Shares Outstanding: 12,714,000

IRADIMED CORP (IRMD) — SEC Financial Statements & Analysis

IRADIMED CORP (IRMD) is a surgical & medical instruments & apparatus company, incorporated in DE. IRADIMED CORP trades on Nasdaq as: IRMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IRADIMED CORP reported a 11.21% year-over-year revenue growth, a Gross Profit Margin of 75.86% (TTM), a Debt-to-Equity ratio of 0.13x, a Price-to-Sales (P/S) ratio of 14.12x (TTM), a Price-to-Book (P/B) ratio of 11.98x (TTM), at a market cap of $1.22B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
11.21%
Gross Profit Margin TTM
75.86%
Debt To Equity
0.13x
P/S TTM
14.12x
P/B TTM
11.98x
Market Cap
$1.22B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IRADIMED CORP in?

IRADIMED CORP (IRMD) operates in the Surgical & Medical Instruments & Apparatus industry.

What is IRMD's market cap?

IRADIMED CORP (IRMD) has a market capitalization of $1.22B as of 2026-06-30.

What is IRMD's P/E ratio?

IRADIMED CORP (IRMD)'s trailing twelve month P/E ratio is 52.87x as of 2026-06-30.

What exchange does IRMD trade on?

IRADIMED CORP (IRMD) trades on the Nasdaq.

Where is IRADIMED CORP incorporated?

IRADIMED CORP is incorporated in DE.

Wall Street's data.
Main Street's price.